Public-private partnerships in translational medicine: Concepts and practical examples

Journal of Controlled Release

Volumn 161, Issue 2, 2012, Pages 416-421

  Luijten, Peter R ^a   Van Dongen, Guus A M S ^b   Moonen, Chrit T ^c   Storm, Gert ^d,e   Crommelin, Daan J A ^f  

^a High Tech Campus 84   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

^e MIRA Institute for Biomedical Technology and Technical Medicine   (Netherlands)

^f LYGATURE   (Netherlands)

Author keywords

HIFU; Image guided drug delivery; MRI; PET; Public private partnerships

Indexed keywords

DRUG DEVELOPMENT; EUROPEAN INITIATIVES; HIFU; HIGH INTENSITY FOCUSED ULTRASOUND; IMAGE-GUIDED; LIFE-SCIENCES; MULTI-DISCIPLINARY RESEARCH; NETHERLANDS; NEW PRODUCT; PUBLIC PRIVATE PARTNERSHIPS; REGENERATIVE MEDICINE; TRANSLATIONAL MEDICINE; TRANSLATIONAL RESEARCH; ULTRA-HIGH;

DRUG DELIVERY; MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; POLYETHYLENE TEREPHTHALATES; ULTRASONIC TESTING;

DIAGNOSIS;

CARBON 11; DASB C 11; DOCETAXEL C 11; ERLOTINIB C 11; FALLYPRIDE F 18; FLUMAZENIL C 11; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; FP BETA CIT F 18; GALLIUM 68; IODINE 124; LANIQUIDAR C 11; METHYLCHOLINE F 18; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE C 11; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; NITROGEN 13; OXYGEN 15; PHOSPHORUS 31; R 107474 C 11; R 116301 C 11; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; SORAFENIB C 11; TRASTUZUMAB ZR 29; UNCLASSIFIED DRUG;

DRUG DELIVERY SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; REVIEW; TRANSLATIONAL RESEARCH; ULTRASOUND;

ANIMALS; DRUG INDUSTRY; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; NETHERLANDS; POSITRON-EMISSION TOMOGRAPHY; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; TRANSLATIONAL MEDICAL RESEARCH; UNIVERSITIES;

EID: 84862642868     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.03.012     Document Type: Review

References (21)

1. R. Becker, G.A. van Dongen, EATRIS, a vision for translational research in Europe, J. Cardiovasc. Transl. Res. 4 (3) (2011) 231-237.
2. R. Weissleder, Molecular imaging: exploring the next frontier, Radiology 212 (3) (1999) 609-614.
3. W. Cai, J. Rao, S.S. Gambhir, X. Chen, How molecular imaging is speeding up antiangiogenic drug development, Mol. Cancer Ther. 5 (11) (2006) 2624-2633.
4. R. Frank, R. Hargreaves, Clinical biomarkers in drug discovery and development, Nat. Rev. Drug Discov. 2 (7) (2003) 566-580.
5. M. Rudin, R. Weissleder, Molecular imaging in drug discovery and development, Nat. Rev. Drug Discov. 2 (2) (2003) 123-131.
6. V. Tolmachev, S. Stone-Elander, A. Orlova, Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls, Lancet Oncol. 11 (10) (2010) 992-1000.
7. E.C. Dijkers, T.H. Oude Munnink, J.G. Kosterink, A.H. Brouwers, P.L. Jager, de J Jr., G.A. van Dongen, C.P. Schroder, M.N. Lub-de Hooge, E.G. de Vries, Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer, Clin. Pharmacol. Ther. 87 (5) (2010) 586-592.
8. G.A. van Dongen, M.J. Vosjan, Immuno-positron emission tomography: shedding light on clinical antibody therapy, Cancer Biother. Radiopharm. 25 (4) (2010) 375-385.
9. J.N. Tinianow, H.S. Gill, A. Ogasawara, J.E. Flores, A.N. Vanderbilt, E. Luis, R. Vandlen, M. Darwish, J.R. Junutula, S. Williams, J. Marik, Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET, Nucl. Med. Biol. 37 (2010) 289-297.
10. S. van R, M.L. Maat-Schieman, R.J. Nabuurs, L. van der W, S. van D, S.G. van Duinen, R. Natte, M.A. van Buchem, J. van der Grond, Cerebral amyloidosis: postmortem detection with human 7.0-T MR imaging system, Radiology 253 (3) (2009) 788-796.
11. W.L. de Graaf, J.J. Zwanenburg, F. Visser, M.P. Wattjes, P.J. Pouwels, J.J. Geurts, C.H. Polman, F. Barkhof, P.R. Luijten, J.A. Castelijns, Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR, Eur. Radiol. 22 (1) (2012) 221-231.
12. M.A. Korteweg, W.B. Veldhuis, F. Visser, P.R. Luijten, W.P. Mali, P.J. van Diest, M.A. van den Bosch, D.J. Klomp, Feasibility of 7 Tesla breast magnetic resonance imaging determination of intrinsic sensitivity and high-resolution magnetic resonance imaging, diffusion-weighted imaging, and (1)H-magnetic resonance spectroscopy of breast cancer patients receiving neoadjuvant therapy, Invest. Radiol. 46 (6) (2011) 370-376.
13. B. Ross, T. Tran, P. Bhattacharya, D.M. Watterson, N. Sailasuta, Application of NMR spectroscopy in medicinal chemistry and drug discovery, Curr. Top. Med. Chem. 11 (1) (2011) 93-114.
14. J.M. Stone, Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia, Curr. Pharm. Des. 15 (22) (2009) 2594-2602.
15. R. Deckers, C.T. Moonen, Ultrasound triggered, image guided, local drug delivery, J. Control. Release 148 (1) (2010) 25-33.
16. A.L. Klibanov, Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications, Invest. Radiol. 41 (3) (2006) 354-362.
17. V. Frenkel, Ultrasound mediated delivery of drugs and genes to solid tumors, Adv. Drug Deliv. Rev. 60 (10) (2008) 1193-1208.
18. de Smet, E. Heijman, S. Langereis, N.M. Hijnen, H. Grull, Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study, J. Control. Release 150 (1) (2011) 102-110.
19. A.H. Negussie, P.S. Yarmolenko, A. Partanen, A. Ranjan, G. Jacobs, D. Woods, H. Bryant, D. Thomasson, M.W. Dewhirst, B.J. Wood, M.R. Dreher, Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound, Int. J. Hyperthermia 27 (2) (2011) 140-155.
20. R. Staruch, R. Chopra, K. Hynynen, Localised drug release using MRI-controlled focused ultrasound hyperthermia, Int. J. Hyperthermia 27 (2) (2011) 156-171.
21. R. Deckers, A. Yudina, L.C. Cardoit, C.T. Moonen, A fluorescent chromophore TOTO-3 as a 'smart probe' for the assessment of ultrasound-mediated local drug delivery in vivo, Contrast Media Mol. Imaging 6 (4) (2011) 267-274.